Skip to contentS
Skye Bioscience, Inc.
S
SKYESkye Bioscience, Inc. Released May 9, 2019, after the close
10-Q filed May 10, 2019, 40 days after period end · 0001640334-19-000805
Q1 2019 · 10-Q
Revenue—
Net Income-$14.77M-$14.77MN/M vs Q1 2018N/M vs Q4 2018 EPS Diluted
No earnings release is on file for this quarter. Its figures came with the 10-Q.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Skye Bioscience, Inc. · CIK 1516551 · Engraved from SEC EDGAR
-$0.11-$0.11N/M vs Q1 2018no prior Q4 2018 on file Operating Income-$1,515,067N/M Operating Cash Flow-$1,431,120N/M Filing lag
ended Mar 31, 2019 · filed May 10, 2019 · 40 d after period end